0000899243-22-004956.txt : 20220207
0000899243-22-004956.hdr.sgml : 20220207
20220207082844
ACCESSION NUMBER: 0000899243-22-004956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220204
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THERO JOHN F
CENTRAL INDEX KEY: 0001199637
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40499
FILM NUMBER: 22595556
MAIL ADDRESS:
STREET 1: C/O AMARIN PHARMA, INC.
STREET 2: 1430 ROUTE 6
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-285-4140
MAIL ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING A, SUITE 510
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-04
0
0001662244
Cyteir Therapeutics, Inc.
CYT
0001199637
THERO JOHN F
128 SPRING ST, BUILDING A, SUITE 510
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to Buy)
5.91
2022-02-04
4
A
0
28300
0.00
A
2032-02-04
Common Stock
28300
28300
D
The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of February 4, 2022, subject to the Reporting Person's continued service to the board of directors of the Issuer through the applicable vesting date.
/s/ Andrew Gengos, Attorney-in-Fact
2022-02-07